Bio-Rad Laboratories, Inc. (BIO)

Bio-Rad Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-2,164	-1,844	-637.3	-3,628	4,254	3,814
Depreciation & Amortization	152.6	151.6	145.9	137.3	137.6	175.7
Loss (Gain) From Sale of Assets	-	-	-2.5	-1.4	-	-11.7
Asset Writedown & Restructuring Costs	29.5	29.5	-	-	-	-
Loss (Gain) From Sale of Investments	3,047	2,657	1,252	5,206	-4,925	-4,491
Stock-Based Compensation	62.3	62.3	61.3	60.9	51.2	41.6
Other Operating Activities	19	20	-12	22.1	8.74	-32.53
Change in Accounts Receivable	16	16.2	11.4	-87.4	-20.4	-15
Change in Inventory	-0.6	8.5	-46.3	-158.8	46.1	-52.1
Change in Accounts Payable	33.3	-40.9	-51.8	-94.2	69.9	124.7
Change in Income Taxes	17.5	24.1	-21.3	-1.2	-28.8	39
Change in Other Net Operating Assets	14.4	-1.9	-2.2	-26.8	-8.6	10.9
Operating Cash Flow	515.3	455.2	374.9	194.4	669.5	585
Operating Cash Flow Growth	48.68%	21.42%	92.85%	-70.96%	14.44%	27.76%
Capital Expenditures	-159.8	-165.6	-156.7	-112.8	-133.75	-108.56
Sale of Property, Plant & Equipment	0.1	0.1	0.2	0.2	0.05	0.07
Cash Acquisitions	-	-	-	-100.7	-125.52	-96.66
Divestitures	-	-	2.5	1.4	-	12.24
Sale (Purchase) of Intangibles	-23.4	-23.4	-	-1.5	-	3.41
Investment in Securities	68.9	28.7	174.2	-994.2	-84.73	119.6
Investing Cash Flow	-114.2	-160.2	20.2	-1,208	-797.38	-69.89
Long-Term Debt Issued	-	-	-	1,186	-	-
Long-Term Debt Repaid	-	-0.4	-0.5	-0.5	-3.02	-426.94
Net Debt Issued (Repaid)	-0.3	-0.4	-0.5	1,186	-3.02	-426.94
Issuance of Common Stock	18	19.2	18.5	17.6	20.63	20.2
Repurchase of Common Stock	-304.2	-207	-443.6	-229.7	-72.48	-112.93
Other Financing Activities	-30	-30.6	-	-	-0.56	-3.37
Financing Cash Flow	-316.5	-218.8	-425.6	973.6	-55.43	-523.04
Foreign Exchange Rate Adjustments	4.7	9.2	0.4	3	-12.64	12.43
Miscellaneous Cash Flow Adjustments	-	-	-	-	-0.04	-0.03
Net Cash Flow	89.3	85.4	-30.1	-36.6	-195.98	4.46
Free Cash Flow	355.5	289.6	218.2	81.6	535.75	476.44
Free Cash Flow Growth	91.74%	32.72%	167.40%	-84.77%	12.45%	32.58%
Free Cash Flow Margin	13.99%	11.28%	8.17%	2.91%	18.33%	18.72%
Free Cash Flow Per Share	12.66	10.26	7.47	2.74	17.74	15.80
Cash Income Tax Paid	103.5	99.4	129.6	158.3	134.68	65.24
Levered Free Cash Flow	250.23	180.86	106.85	2.86	485.98	427.88
Unlevered Free Cash Flow	280.61	211.43	137.72	26.68	486.95	441.54
Change in Net Working Capital	-77.53	-18.4	123.9	358.85	-78.94	-66.07

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q